Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer

Authors: Weiner, Adam B, Agrawal, Raag, Wang, Nicholas K, Sonni, Ida, Li, Eric V, Arbet, Jaron, Zhang, JJH, Proudfoot, James A, Hong, Boon Hao, Davicioni, Elai, Kane, Nathanael, Valle, Luca F, Kishan, Amar U, Dal Pra, Alan, Ghadjar, Pirus, Sweeney, Christopher J, Nickols, Nicholas G, Karnes, R Jeffrey, Shen, John, Rettig, Matthew B, Czernin, Johannes, Ross, Ashely E, Chua, Melvin Lee Kiang, Schaeffer, Edward M, Calais, Jeremie, Boutros, Paul C, Reiter, Robert E

Source: European Urology. 86(6)

Subject Terms: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Prostate Cancer, Radiation Oncology, Health Disparities, Genetics, Cancer, Aging, Biomedical Imaging, Urologic Diseases, Minority Health, Male, Humans, Prostatic Neoplasms, Glutamate Carboxypeptidase II, Antigens, Surface, Aged, Positron-Emission Tomography, Biomarkers, Tumor, Middle Aged, Prostatic neoplasms/genetics, Prostatic neoplasms/pathology, Gene expression, Biomarkers, Tumor, Prognosis, Gene expression profiling, Urology & Nephrology, Clinical sciences

File Description: application/pdf

Access URL: https://escholarship.org/uc/item/9bt5w5vj
https://escholarship.org/content/qt9bt5w5vj/qt9bt5w5vj.pdf

A sample selection strategy to boost the statistical power of signature detection in cancer expression profile studies.

Authors: Jia, Zhenyu, Wang, Yipeng, Hu, Yuanjie, McLaren, Christine, Yu, Yingyan, Ye, Kai, Xia, Xiao-Qin, Koziol, James A, Lernhardt, Waldemar, McClelland, Michael, Mercola, Dan

Source: Anti-cancer agents in medicinal chemistry. 13(2)

Subject Terms: Biomarkers, Tumor: genetics, Data Interpretation, Statistical, Gene Expression Profiling, Humans, Male, Prostatic Neoplasms: genetics, pathology

File Description: application/pdf

Access URL: https://escholarship.org/uc/item/9mt45296

The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.

Authors: Simoneau, Anne R, Gerner, Eugene W, Nagle, Ray, Ziogas, Argyrios, Fujikawa-Brooks, Sharon, Yerushalmi, Hagit, Ahlering, Thomas E, Lieberman, Ronald, McLaren, Christine E, Anton-Culver, Hoda, Meyskens, Frank L, Jr

Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(2)

Subject Terms: Adult, Aged, Antineoplastic Agents: pharmacology, Biopsy, Eflornithine: pharmacology, Genotype, Humans, Male, Middle Aged, Polyamines: metabolism, Polymorphism, Genetic, Prostate: drug effects, pathology, Prostate-Specific Antigen: blood, Prostatic Neoplasms: genetics, metabolism, pathology, prevention & control, Statistics, Nonparametric, Tumor Markers, Biological: blood, biological marker, eflornithine, ornithine decarboxylase, placebo, polyamine, prostate specific antigen, putrescine, adult, aged, article, audiography, cancer growth, cancer size, chemoprophylaxis, clinical trial, controlled clinical trial, controlled study, double blind procedure, drug mechanism, erectile dysfunction, gastrointestinal symptom, genotype, hearing, human, human tissue, hyperplasia, intervertebral disk disease, major clinical study, male, men's health, musculoskeletal disease, ototoxicity, phase 2 clinical trial, priority journal, prostate cancer, randomized controlled trial, sexual dysfunction, side effect, tendinitis, tinnitus, tumor biopsy, unspecified side effect, vertigo, Adult, Aged, Antineoplastic Agents, Biopsy, Eflornithine, Genotype, Humans, Male, Middle Aged, Polyamines, Polymorphism, Genetic, Prostate, Prostate-Specific Antigen, Prostatic Neoplasms, Statistics, Nonparametric, Tumor Markers, Biological

File Description: application/pdf

Access URL: https://escholarship.org/uc/item/5s85500z